MovDisordV3, Main, Curation, bibRecord, 004475

Entacapone in restless legs syndrome

Identifieur interne : 004475 ( Main/Curation ); précédent : 004474; suivant : 004476

Entacapone in restless legs syndrome

Auteurs : Ashfaq A. Sharif [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2002-03.

RBID : ISTEX:CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4

Descripteurs français

Pascal (Inist)
- Antiparkinsonien, Carbidopa, Chimiothérapie, Entacapone, Etude cas, Homme, Impatience membre inférieur syndrome, Lévodopa, Traitement associé.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antiparkinson Agents (administration & dosage), Antiparkinson agent, Carbidopa, Carbidopa (administration & dosage), Case study, Catechols (administration & dosage), Chemotherapy, Combined treatment, Delayed-Action Preparations, Drug Combinations, Drug Therapy, Combination, Entacapone, Female, Human, Humans, Levodopa, Levodopa (administration & dosage), Middle Aged, Neurologic Examination (drug effects), Nitriles, Restless Legs Syndrome (drug therapy), Restless legs syndrome.
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Catechols, Levodopa.
- chemical : Delayed-Action Preparations, Drug Combinations, Nitriles.
- drug effects : Neurologic Examination.
- drug therapy : Restless Legs Syndrome.
- Drug Therapy, Combination, Female, Humans, Middle Aged.

Abstract

Entacapone increased the duration of action of carbidopa–levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea. ©2002 Movement Disorder Society.

Url:

https://api.istex.fr/document/CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4/fulltext/pdf

DOI: 10.1002/mds.10080

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001947
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001947
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002D66
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006480
to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002769
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000552
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002771
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006810
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003B06
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003B06
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003B01
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000745
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000745
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000745
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006199

Links to Exploration step

ISTEX:CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10080</idno>
<idno type="url">https://api.istex.fr/document/CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001947</idno>
<idno type="wicri:Area/Istex/Curation">001947</idno>
<idno type="wicri:Area/Istex/Checkpoint">002D66</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006480</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:02-0313696</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002769</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000552</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002771</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006810</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11921139</idno>
<idno type="wicri:Area/PubMed/Corpus">003B06</idno>
<idno type="wicri:Area/PubMed/Curation">003B06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B01</idno>
<idno type="wicri:Area/Ncbi/Merge">000745</idno>
<idno type="wicri:Area/Ncbi/Curation">000745</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000745</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006199</idno>
<idno type="wicri:Area/Main/Curation">004475</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-03">2002-03</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="421">421</biblScope>
<biblScope unit="page" to="421">421</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4</idno>
<idno type="DOI">10.1002/mds.10080</idno>
<idno type="ArticleID">MDS10080</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson agent</term>
<term>Carbidopa</term>
<term>Carbidopa (administration & dosage)</term>
<term>Case study</term>
<term>Catechols (administration & dosage)</term>
<term>Chemotherapy</term>
<term>Combined treatment</term>
<term>Delayed-Action Preparations</term>
<term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Entacapone</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (administration & dosage)</term>
<term>Middle Aged</term>
<term>Neurologic Examination (drug effects)</term>
<term>Nitriles</term>
<term>Restless Legs Syndrome (drug therapy)</term>
<term>Restless legs syndrome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Catechols</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Delayed-Action Preparations</term>
<term>Drug Combinations</term>
<term>Nitriles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Carbidopa</term>
<term>Chimiothérapie</term>
<term>Entacapone</term>
<term>Etude cas</term>
<term>Homme</term>
<term>Impatience membre inférieur syndrome</term>
<term>Lévodopa</term>
<term>Traitement associé</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Entacapone increased the duration of action of carbidopa–levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea. ©2002 Movement Disorder Society.</div>
</front>
</TEI>
<double idat="0885-3185:2002:Sharif A:entacapone:in:restless"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Neurologic Consultants, P.A.</s1>
<s2>Maplewood, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">02-0313696</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0313696 INIST</idno>
<idno type="RBID">Pascal:02-0313696</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002769</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000552</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002771</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006810</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Neurologic Consultants, P.A.</s1>
<s2>Maplewood, Minnesota</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Carbidopa</term>
<term>Case study</term>
<term>Chemotherapy</term>
<term>Combined treatment</term>
<term>Entacapone</term>
<term>Human</term>
<term>Levodopa</term>
<term>Restless legs syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Impatience membre inférieur syndrome</term>
<term>Entacapone</term>
<term>Antiparkinsonien</term>
<term>Carbidopa</term>
<term>Lévodopa</term>
<term>Chimiothérapie</term>
<term>Traitement associé</term>
<term>Homme</term>
<term>Etude cas</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Entacapone increased the duration of action of carbidopa-levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10080</idno>
<idno type="url">https://api.istex.fr/document/CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001947</idno>
<idno type="wicri:Area/Istex/Curation">001947</idno>
<idno type="wicri:Area/Istex/Checkpoint">002D66</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006480</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Entacapone in restless legs syndrome</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A." last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-03">2002-03</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="421">421</biblScope>
<biblScope unit="page" to="421">421</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4</idno>
<idno type="DOI">10.1002/mds.10080</idno>
<idno type="ArticleID">MDS10080</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Entacapone increased the duration of action of carbidopa–levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea. ©2002 Movement Disorder Society.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Entacapone in restless legs syndrome.</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A" last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurologic Consultants, P.A., Maplewood, Minnesota, USA. nawazone@yahoo.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:11921139</idno>
<idno type="pmid">11921139</idno>
<idno type="wicri:Area/PubMed/Corpus">003B06</idno>
<idno type="wicri:Area/PubMed/Curation">003B06</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B01</idno>
<idno type="wicri:Area/Ncbi/Merge">000745</idno>
<idno type="wicri:Area/Ncbi/Curation">000745</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000745</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno>
<idno type="wicri:Area/Main/Merge">006199</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Entacapone in restless legs syndrome.</title>
<author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A" last="Sharif">Ashfaq A. Sharif</name>
<affiliation wicri:level="2"><nlm:affiliation>Neurologic Consultants, P.A., Maplewood, Minnesota, USA. nawazone@yahoo.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea>
<placeName><region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term>
<term>Carbidopa (administration & dosage)</term>
<term>Catechols (administration & dosage)</term>
<term>Delayed-Action Preparations</term>
<term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Middle Aged</term>
<term>Neurologic Examination (drug effects)</term>
<term>Nitriles</term>
<term>Restless Legs Syndrome (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Carbidopa</term>
<term>Catechols</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Delayed-Action Preparations</term>
<term>Drug Combinations</term>
<term>Nitriles</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Entacapone increased the duration of action of carbidopa-levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004475 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004475 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:CF1A4F3B7D460BC8A1B5E1E111FD658A59FF8CD4
   |texte=   Entacapone in restless legs syndrome
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Entacapone in restless legs syndrome

Entacapone in restless legs syndrome

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri